Healthcare Analytical Testing Services Trends News

The report "Healthcare Analytical Testing Services Market By Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030", is projected to reach USD 12.48 billion by 2030 from USD 7.48 billion in 2025, growing at a CAGR of 10.8% during the forecast period.

Browse 446 market data Tables and 61 Figures spread through 435 Pages and in-depth TOC on "Healthcare Analytical Testing Services Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/healthcare-analytical-testing-services-market-108923833.html

The key factors driving the growth of the healthcare analytical testing services market include the increasing outsourcing of analytical testing by pharmaceutical and medical device companies, the rising number of clinical trials, and the growing research and development expenditure in the pharmaceutical and biopharmaceutical industries. The heightened focus on analytical testing of biologics and biosimilars is expected to create additional market opportunities during the forecast period. Furthermore, intense competition among industry players can enhance brand protection efforts. Additionally, untapped emerging markets present further opportunities for market growth.

By type, the bioanalytical testing services segment is expected to grow significantly from 2025 to 2030.

By type, the bioanalytical testing services segment is expected to dominate the market during the forecast period. The healthcare analytical testing services market is categorized into bioanalytical testing services, physical characterization services, method development & validation services, stability testing services, batch-release testing services, raw material testing services, microbial testing services, environmental monitoring services, genomic testing services, and other analytical testing services. The bioanalytical testing services segment comprises pharmacokinetic & toxicokinetic testing, immunogenicity & neutralizing antibody testing, biomarker testing, bioassay testing, and other bioanalytical testing services. Key factors driving the growth of the bioanalytical testing services segment during this period include the exorbitant costs of drug discovery and development and time constraints in biopharmaceutical research that can be controlled through effective bioanalysis.

By end user, the pharmaceutical companies segment accounted for the largest share of the healthcare analytical testing services market in 2024.

In 2024, the pharmaceutical companies segment accounted for the largest market share of the healthcare analytical testing services market. This significant market presence, driven by the trend of companies outsourcing analytical testing services, is expected to fuel growth in this segment in the coming years.

By region, the Asia Pacific is expected to register the highest growth rate during the forecast period.

The Asia Pacific region is expected to register the highest CAGR in the healthcare analytical testing services market. This region includes countries such as China, India, South Korea, Taiwan, and Singapore. The growth of the healthcare analytical testing services market is driven by the rising outsourcing of drug discovery & development activities undertaken by emerging economies due to low labor costs and the growth of the biopharmaceutical industry in the region.

Key Players

As of 2024, the leading companies in the healthcare analytical testing services market include Eurofins Scientific SE (Luxembourg), LabCorp Holdings Inc. (US), WuXi AppTec (China), Charles River Laboratories (US), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Medpace Holdings, Inc. (US), Sartorius AG (Germany), Intertek Group Plc (UK), Merck KGaA (Germany), and SourceBio International Limited (UK).

Don’t miss out on business opportunities in Healthcare Analytical Testing Services Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/